Balkan endemic nephropathy (BEN) is of great clinical importance in restricted areas of the Balkany. In these countries, BEN, a chronic tubulointerstitial kidney disease, is regarded as a national problem of majority1. The onset is in childhood with a latent period of several decades and it is clinically expressed usually only at an advanced stage of renal failure. A female predominance was established. BEN is characterized by anemia, absence of hypertension, gradually destroyed renal function, a low-degree proteinuria and poor urinary sediment. The pathologic process progresses to intense fibrosis and tubular atrophy, and at the end stage of the disease, renal failure develops. About 30% to 48% of BEN patients develop transitional-cell tumors of the upper urothelium. Tumors are usually malignant, multiple, and two thirds have bilateral localization in the renal pelvis, one third in the urethra and in the bladder2.
The etiology of BEN is unknown. Different hypotheses try to explain the striking endemic distribution of the disease with an etiologic role of genetic factors, exogenous factors (i.e., heavy metals, fungal toxins as ochratoxin A, inorganic compounds), or infectious agents3,4,5,6,7,8,9,10,11.
Concepts of the possible role of hereditary factors and infectious agents as well as predisposition to tumor development suggest an involvement of immune mechanisms in the pathogenesis of the disease.
In this study, urine samples of BEN patients were collected and tested for the concentration of neopterin. Neopterin is produced in large amounts by monocyte-derived macrophages upon activation with Th1-type cytokine interferon-
, and increased neopterin concentrations are characteristic for cellular immune activation12,13.
METHODS
Five endemic villages from Vratza district (Gorno Peshtene, Tishevitza, Vesletz, Beli Izvor, and Pudria), all in Bulgaria, were screened for BEN. First-morning urine samples from 48 patients (41 women and seven men; age, 65.5
6.9 years; range, 52 to 79 years) with BEN living in the endemic area were collected. Specimens were kept at –20°C until measured.
Clinical investigations comprised blood tests [hemoglobin concentrations, red blood cells, leukocytes, and erythrocyte sedimentation rate (ESR), blood urea, creatinine, and uric acid] and urine analyses (pH, protein, glucose, bilirubin, urobilinogene, blood, nitrite, specific urine weight, ketons, and leukocytes). None of the patients showed symptomatology of any acute viral infection.
Neopterin and creatinine concentrations in urine samples were determined by high-pressure liquid chromatography (HPLC)12. Briefly 100 mL of urine was diluted in 1 mL 15 mmol/L Soerensen potassium phosphate buffer, pH 6.4 containing 5 mmol/L ethylenediaminetetraacetic acid (EDTA). Neopterin and creatinine were separated by reversed-phase HPLC and expressed as
mol neopterin per mol creatinine ratio to take into account variations of urine dilution12. As stationary phase, a LiChroCART 125-4 column (RP-18 endcapped, grain size 5
m) (Merck, Darmstadt, Germany) was used, the mobile phase was a 15 mmol/L potassium phosphate buffer, pH 6.4 (Soerensen). Neopterin was quantified by its natural fluorescence (excitation at 353 nm wavelength; emission at 438 nm wavelength) and creatinine was simultaneously quantified by ultraviolet absorption at 235 nm wavelength in one single run12. HPLC measurements were performed in subsequent runs within 1 day. Intra-assay variation of the HPLC method is
6%12.
Preliminary virus analyses could be performed only in a subgroup of 34 individuals. By indirect immunofluorescence, antibodies against nephrotopic viruses with endemic areas of circulation [e.g., hantaviruses (hantavirus strains, standard Hantaan and F3955, local B1)] and West Nile flavivirus virus were analyzed.
Because not all laboratory results showed normal distribution, for comparisons of groups nonparametric Mann Whitney U-test was employed. Associations between neopterin concentrations, age, and other laboratory results of patients were calculated by Spearman rank correlation analysis.
RESULTS
Demographic data and neopterin concentrations in the individual urine samples are shown in Table 1. Increased neopterin concentrations were observed in 50% of the BEN patients, as compared to the 95th percentile of healthy controls12Table 1. Mean neopterin concentration was 263.1
mol/mol creatinine (see Table 2), which exceeds the upper limits of normal for men and women of all age groups. Elevated ESRs, as well as decreased hemoglobin concentrations, were also evident in the patients Table 2.
Table 1 - Demographic characteristics and neopterin concentrations in urine samples of Balkan endemic nephropathy (BEN) patients.
Table 2 - Neopterin concentrations and erythrocyte sedimentation rates (ESR) in 48 patients with Balkan endemic nephropathy (BEN).
There was no difference of neopterin concentrations between men and women, and there existed no correlations between neopterin and age and also not to other available laboratory parameters Table 3. Creatinine concentrations correlated positively with ESRs and inversely with hemoglobin levels. In addition, lower hemoglobin levels were associated with higher ESRs Table 2. When splitting the patients into two groups at the median creatinine concentration (=132
mol/L), the group with higher creatinine concentrations presented with lower hemoglobin (mean
SD, 101.5
15.7 g/L; P < 0.001) and higher ESRs (ESR 1 hour, 33.8
16.0 mm/hour; P = 0.01) as compared with the group with lower creatinine (hemoglobin, 118.9
10.6 g/L; ESR 1 hour, 22.9
10.4 mm/hour). No such differences were found for age and urinary neopterin concentrations. Of the two patients on hemodialysis, one presented with the highest (=786
mol neopterin/mol creatinine), the other with the lowest neopterin concentration (=78
mol neopterin/mol creatinine) of all patients. Age correlated only weakly and positively with creatinine and ESRs and negatively with hemoglobin, and when patients were split in two groups at the median of their age (=65 years), there was no difference between any of the parameters (all P> 0.05).
Table 3 - Associations between age and laboratory characteristics of patients with Balkan endemic nephropathy (BEN).
There was no difference between any of the measured parameters in cases with and without BEN family history. BEN patients with diagnosed malignancy were older (73.0
3.67 years; N = 5) than those without such diagnosis (64.6
6.63 years, P < 0.01), but again, none of the laboratory parameters differed between the two groups of BEN patients. All the results of statistical analyses did not change when two patients on hemodialysis were excluded.
Preliminary data in a subgroup of 34 patients revealed comparatively low levels of antibodies against hantavirus strains (standard Hantaan and F3955, local B1) in nine patients (27%) Table 4. Besides, in two cases (two out of 34) (6%) anti-West Nile virus antibodies have been recorded Table 4. There was no association between the serologic findings and any of the laboratory measurements with the exception of neopterin: neopterin concentrations were lower in the 5 females seropositive for local hantavirus strain B1 (168.2 + 66.1
mol neopterin/mol creatinine) compared to residual seronegative BEN patients (279.3 + 144.3
mol neopterin/mol creatinine; U = 1.98, P < 0.05).
Table 4 - Antibodies against West Nile virus (WNV) and hantavirus strains in serum samples of 34 patients with Balkan endemic nephropathy (BEN) (indirect immunofluorescence test).
DISCUSSION
The monitoring of neopterin concentrations in body fluids is a sensitive way to detect Th1-type immune response12,13 initiated by various causes. Measurements of neopterin concentrations in urine, serum or cerebrospinal fluid are employed as a laboratory diagnostic tool (e.g., to earlier detect immunologic complications in transplant recipients or to predict prognosis in HIV infection and malignancy)12. Neopterin concentrations are also increased with high frequency during acute virus infections12,14. Neopterin concentrations were found to be increased during episodes of viral infection, including acute hepatitis A and B15, Epstein-Barr virus (mononucleosis), cytomegalovirus14,16, and measles17. In cytomegalovirus infections16, increased neopterin concentrations are observed in the majority of patients before antibody seroconversion becomes detectable. Usually neopterin concentrations normalize after seroconversion and when clinical symptomatology has ceased. However, elevated serum and urine neopterin concentrations levels cannot only be detected in acute and late stage of HIV infection, they are also found in more than 75% of patients with asymptomatic HIV-1 infection18,19.
Renal impairment may increase blood neopterin concentrations18. Therefore, we decided to determine urinary neopterin concentrations expressed as the neopterin per creatinine ratio. Data of this study show that there was no relationship between serum creatinine and urine neopterin concentrations when expressed as
mol neopterin/mol creatinine. The lacking association between creatinine and urinary neopterin concentrations is further strengthened by the observation that patients on hemodialysis (N = 2) presented, on the one hand, with the lowest and, on the other, with the highest neopterin concentrations of the study population.
Because, among other reasons, viral infection is discussed as a possible cause for BEN8,9,10,11, it was of interest to examine neopterin concentrations in urine samples from BEN patients. However, only 50% of BEN patients presented with elevated neopterin concentrations compared to healthy controls. There was no difference between BEN patients with and without family history. Survival of BEN cases with family history was found longer when compared with BEN cases without family history20. Again, these subgroups in our study did not differ regarding their neopterin concentrations. Only a few patients tested weakly positive for antibodies against hantavirus strains or anti-West Nile virus. Five females seropositive for local hantavirus strain B1 had lower neopterin concentrations than seronegative BEN patients. The number of patients tested was limited and the titers measured were low, still the result would fit to the earlier observation that higher neopterin concentrations, indicating cellular (=Th1-type) immune activation, are related to lower Th2-type markers such as IgE or antibody titers21,22 in the sense of a cross-regulatory influence of Th1- versus Th2-type cytokines. Nevertheless, our observations would fit the notion that at least half of the patients examined in this study do not comprise patients suffering from acute virus infections.
Earlier studies show that malignant tumor diseases are frequently associated with increased neopterin concentrations23. Thereby, higher neopterin concentrations are associated with shortened survival. Half of the BEN patients presented with increased neopterin concentrations, which is similar to the frequencies with elevated neopterin observed earlier in patients with solid cancer such as gynecologic neoplasias or cancer of the prostate. However, only a minority of our BEN patients presented with tumors, and their neopterin concentrations did not differ from patients without such diagnosis. A possible predictive value of neopterin concentrations still has to be demonstrated.
In several malignant and infectious diseases, an association between higher neopterin concentrations and lower hemoglobin concentrations was observed24. This was not found in our study population. In addition, in chronic or protracted infections very often an association exists between neopterin concentrations and ESR24,25,26, again this was not true in our individuals. With this respect, patients with BEN differ considerably from observations made in patients with infections or malignant diseases.
The lack of a strong increase of neopterin concentrations may reflect the very slow progression of BEN, the pauci-cellular infiltrates, marked interstitial fibrosis without prominent inflammation. The absence of elevated neopterin concentrations in patients with malignant tumors might be due to the characteristically superficial, epithelial type of tumors seen in BEN patients. Overall, the absence of increased neopterin in half of the patients might support the hypothesis of a toxic nephropathy with a genetic predisposition and may argue against an ongoing viral infection.
CONCLUSION
Approximately 50% of BEN patients present with increased urinary neopterin levels. The patients with elevated neopterin levels did not have a higher degree of renal insufficiency, and there were no differences in other variables studied between the patients with increased neopterin and those with normal values. The background of this elevation, whether it is infectious or of other origin, remains unresolved. Also, an association between higher neopterin and ESR or lower hemoglobin concentrations, which is commonly observed in infections and malignant processes, is obviously missing in patients with BEN.
References
| 1. | GLUHOVSCHI G, STEFANOVIC V & DIMITROV T. Endemic Balkan Nephropathy,. 1994; Timisoara, Helicon. |
| 2. | Pfohl-Leszkowicz A, Petkova-Bocharova T, Chernozemsky IN & Castegnaro M. Balkan endemic nephropathy and associated urinary tract tumours: A review on aetiological causes and the potential role of mycotoxins. Food Addit Contam 2002; 19: 282−302. | Article | PubMed | ISI | ChemPort | |
| 3. | Toncheva D & Dimitrov TZ. Genetic predisposition to Balkan endemic nephropathy. Nephron 1996; 72: 564−569. | PubMed | ISI | ChemPort | |
| 4. | Toncheva D, Dimitrov TZ & Stoyanova S. Etiology of Balkan endemic nephropathy: A multifactorial disease. Eur J Epid 1998; 14: 389−394. | ISI | ChemPort | |
| 5. | Orem HW, Tatu CA & Feder GL et al. Environment, geochemistry and the etiology of Balkan endemic nephropathy: Lessons from Romania. Facta Universitatis (Belgrade) Medicine and Biology 2002; 9: 39−49. |
| 6. | Mantle PG. Experimental mycotoxic nephropathies and Balkan endemic nephropathy. Facta Universitatis (Belgrade) Medicine and Biology 2002; 9: 39−49. |
| 7. | Nikolov IG, Chernozemski IN & Petkova-Bocharova T et al. Review of the cooperative studies of the National Oncological Centre in Bulgaria on Balkan endemic nephropathy and associated urinary tract tumours (1991−2001). Facta Universitatis (Belgrade) Medicine and Biology 2002; 9: 119−122. |
| 8. | Apostolov K & Spasic P. Evidence of a viral aetiology in endemic (Balkan) nephropathy. Lancet 1975; 2: 1271−1273. | PubMed | ISI | ChemPort | |
| 9. | Georgescu L, Litvac B & Diosi P et al. Viruses in endemic (Balkan) nephropathy. Lancet 1976; 1: 1086. | PubMed | ISI | ChemPort | |
| 10. | Uzelac-Keserovic B, Vasic D & Konomovski J et al. Isolation of a coronavirus from urinary tract tumours of endemic Balkan nephropathy patients. Nephron 2000; 86: 93−94. | PubMed | ISI | ChemPort | |
| 11. | Uzelac-Keserovic B & Apostolov K. Virus isolation from the kidney, tumors and lymph nodes of patients with BEN. Facta Universitatis (Belgrade) Medicine and Biology 2002; 9: 74−75. |
| 12. | Fuchs D, Weiss G, Reibnegger G & Wachter H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992; 29: 307−341. | PubMed | ISI | ChemPort | |
| 13. | Weiss G, Murr C & Zoller H et al. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999; 116: 435−440. | Article | PubMed | ISI | ChemPort | |
| 14. | Kern P, Rokos H & Dietrich M. Raised serum neopterin levels and imbalances of T-lymphocyte subsets in viral diseases, acquired immune deficiency and related lymphadenopathy syndromes. Biomed Pharmacother 1984; 38: 407−411. | PubMed | ISI | ChemPort | |
| 15. | Reibnegger G, Auhuber I & Fuchs D et al. Urinary neopterin levels in acute viral hepatitis. Hepatology 1988; 8: 771−774. | PubMed | ISI | ChemPort | |
| 16. | Mueller TF, Gicklhorn D & Jungraithmayr T et al. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients. J Clin Virol 2002; 24: 45−56. | PubMed | ChemPort | |
| 17. | Griffin DE, Ward BJ & Jauregui E et al. Immune activation during measles: Interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Infect Dis 1990; 161: 449−453. | PubMed | ISI | ChemPort | |
| 18. | Fuchs D, Stahl-Hennig C & Gruber A et al. NeopterinIts clinical use in urinalysis. Kidney Int 1994; 46 Suppl 47: S8−S11. |
| 19. | Fahey JL, Taylor JM & Detels R et al. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N Engl J Med 1990; 322: 166−172. | PubMed | ISI | ChemPort | |
| 20. | Bukvic D, Jankovic S, Dukanovic L & Marinkovic J. Survival of Balkan endemic nephropathy patients. Nephron 2000; 86: 463−466. | PubMed | ISI | ChemPort | |
| 21. | Ledochowski M, Murr C, Widner B & Fuchs D. Inverse relationship between neopterin and immunoglobulin E. Clin Immunol 2001; 98: 104−108. | Article | PubMed | ISI | ChemPort | |
| 22. | Murr C, Hainz U & Asch E et al. Association of increased neopterin production with decreased humoral immunity in the elderly. Exp Gerontol 2003; 38: 583−587. | Article | PubMed | ISI | ChemPort | |
| 23. | Murr C, Fuith LC & Widner B et al. Increased neopterin concentrations in patients with cancer: Indicator of oxidative stress? Anticancer Res 1999; 19: 1721−1728. | PubMed | ISI | ChemPort | |
| 24. | Fuchs D, Hausen A & Reibnegger G et al. Immune activation and the anaemia associated with chronic inflammatory disorders. Eur J Haematol 1991; 46: 65−70. | PubMed | ISI | ChemPort | |
| 25. | Hausen A, Fuchs D & Reibnegger G et al. Neopterin excretion does not correlate with erythrocyte sedimentation rate. Klin Wochenschr 1987; 65: 1173. | Article | PubMed | ISI | ChemPort | |
| 26. | Denz H, Fuchs D & Hausen A et al. Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Klin Wochenschr 1990; 68: 218−222. | Article | PubMed | ISI | ChemPort | |
Acknowledgments
This work was supported by the Austrian Federal Ministry of Social Affairs and Generations, and by INCO-COPERNICUS project ERB IC15-CT98-0318.


